These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19666666)

  • 21. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticoagulant management in patients with atrial fibrillation.
    Fitzmaurice DA; Hobbs FD
    Semin Thromb Hemost; 2009 Sep; 35(6):543-7. PubMed ID: 19787557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anticoagulation therapy in paroxysmal atrial fibrillation].
    Risøe C; Gjesdal K
    Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulation and stroke in atrial fibrillation.
    Boos CJ
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674043
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing the challenge of atrial fibrillation and stroke prevention in older people: new drugs or new approaches to improve outcomes?
    Fuller R; Dudley N
    Age Ageing; 2005 Jul; 34(4):413-4; author reply 414. PubMed ID: 15955767
    [No Abstract]   [Full Text] [Related]  

  • 28. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoeconomics of atrial fibrillation and stroke prevention.
    Bushnell CD; Matchar DB
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S66-71. PubMed ID: 15152748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
    Watson T; Kakar P; Lip GY
    Int J Clin Pract; 2007 Jan; 61(1):6-9. PubMed ID: 17229172
    [No Abstract]   [Full Text] [Related]  

  • 34. Atrial fibrillation: are there gender differences?
    Michelena HI; Ezekowitz MD
    J Gend Specif Med; 2000; 3(6):44-9. PubMed ID: 11253382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?
    Guthmann RA
    Am Fam Physician; 2004 Sep; 70(5):917-8. PubMed ID: 15368730
    [No Abstract]   [Full Text] [Related]  

  • 37. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG; Albers GW
    J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral anticoagulation and stroke in atrial fibrillation.
    Epstein EF; Natarajan I
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
    [No Abstract]   [Full Text] [Related]  

  • 40. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.